MedPath

Radboud University Medical Center

Radboud University Medical Center logo
🇳🇱Netherlands
Ownership
Private
Established
1951-01-01
Employees
-
Market Cap
-
Website
http://www.radboudumc.nl

Pharmacokinetic Study on Raltegravir and Lamotrigine

Phase 1
Completed
Conditions
HIV Infection
Interventions
First Posted Date
2008-02-19
Last Posted Date
2020-10-19
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
24
Registration Number
NCT00618241
Locations
🇳🇱

Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital

Completed
Conditions
Delirium
First Posted Date
2008-01-30
Last Posted Date
2010-08-31
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
700
Registration Number
NCT00604773
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Critical Care, Nijmegen, Gelderland, Netherlands

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Not Applicable
Completed
Conditions
Clear Cell Renal Cell Carcinoma
Interventions
Drug: 111Indium-bevacizumab
Drug: 111Indium-cG250
First Posted Date
2008-01-28
Last Posted Date
2013-12-02
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
26
Registration Number
NCT00602862
Locations
🇳🇱

Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes

Conditions
Myelodysplastic Syndromes (MDS)
Interventions
Other: No interventions
First Posted Date
2008-01-25
Last Posted Date
2020-12-30
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
4000
Registration Number
NCT00600860
Locations
🇦🇹

University of Innsbruck Fachartz fur Innere Medizin, Dept of Hematology, Innsbruck, Austria

🇩🇪

Medizinische Klinik und Poliklinik fur Haematologie, Onkologie und Klinische Immunologie, Dusseldorf, Germany

🇨🇿

Institute of Haematology and Blood Transfusion U nemocnice, Prague, Czechia

and more 15 locations

Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients

First Posted Date
2008-01-09
Last Posted Date
2020-11-30
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
20
Registration Number
NCT00588835
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Rituximab for Prevention of Rejection After Renal Transplantation

Phase 2
Completed
Conditions
Kidney Transplantation
Interventions
Drug: Placebo
First Posted Date
2007-11-29
Last Posted Date
2015-11-10
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
280
Registration Number
NCT00565331
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Lanreotide as Treatment of Polycystic Livers

Phase 2
Completed
Conditions
Polycystic Liver Disease
Hepatomegaly
Liver Diseases
Polycystic Kidney, Autosomal Dominant
Interventions
Drug: Placebo
First Posted Date
2007-11-29
Last Posted Date
2009-02-17
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
38
Registration Number
NCT00565097
Locations
🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

🇳🇱

Radboud University Medical Center, Nijmegen, Netherlands

Comparison of Effectiveness and Costs of Post-diagnosis Treatment in Dementia

Not Applicable
Completed
Conditions
Dementia
Interventions
Other: Multidisciplinary Memory Clinic
Other: General Practitioners
First Posted Date
2007-11-06
Last Posted Date
2011-01-10
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
220
Registration Number
NCT00554047
Locations
🇳🇱

University Medical Centre St Radboud, Alzheimer Centre, Nijmegen, Netherlands

🇳🇱

Catharina hospital, Department of Geriatrics, Eindhoven, Netherlands

🇳🇱

Hospital Gelderse Vallei, Department of Geriatrics, Ede, Netherlands

and more 6 locations

The Effect of Rosuvastatin on Adenosine Metabolism

Not Applicable
Completed
Conditions
Adenosine Metabolism
Interventions
Drug: placebo
First Posted Date
2007-11-06
Last Posted Date
2008-09-23
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
24
Registration Number
NCT00554138
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Does Ascorbic Acid Reduce Sympathoexcitation in CHF?

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Drug: placebo
First Posted Date
2007-10-26
Last Posted Date
2008-10-15
Lead Sponsor
Radboud University Medical Center
Registration Number
NCT00550121
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath